Organised by The University of Melbourne's Graeme Clark Institute of Biomedical Engineering, we are honored to welcome Dr. Milica Radisic from the University of Toronto for this year's oration. A global pioneer in tissue engineering, Dr. Radisic is redefining the landscape of medical research by bridging the gap between engineering and stem cell biology.
How can we study human disease, test new medicines, and predict treatment safety without relying on animal models that often fail to reflect human biology? In this talk, Professor Milica Radisic will present how her team is engineering human tissues on chips. These miniature models of organs (such as the heart, blood vessels and kidney) are built from living human cells. By combining human cells with advanced biomaterials and microengineering, these systems recreate key aspects of human physiology and provide powerful new tools for understanding disease and accelerating drug development.
The lecture will highlight recent advances, including heart tissues that beat and respond to medicines, and engineered blood vessels that can be perfused and remodelled like those in the body. A particular focus will be the emerging role of immune cells as key organisers of tissue function, revealing how interactions between different cell types are essential to building more realistic and predictive models.
Looking ahead, Professor Radisic will explore the future of biomedical research through AI-powered, self-driving laboratories, where robotics and machine learning can design, build and test thousands of experiments. These technologies have the potential to accelerate discovery, improve reproducibility, and enable more scalable, human-relevant research, while also raising important ethical considerations.
By registering for this event, you acknowledge and consent to the taking of photographs during the event. These images may be used for promotional or marketing purposes. If you do not wish to be photographed, please notify event staff on the day.
Professor Milica Radisic
Milica Radisic is a Professor at the University of Toronto, Tier 1 Canada Research Chair in Organ-on-a-Chip Engineering, and Senior Scientist at the Toronto General Research Institute. She is the co-founder of the Center for Research and Applications in Fluidic Technologies (CRAFT) and scientific co-lead of the Human Organ Emulation Self-Driving Laboratory within the Acceleration Consortium.
A Fellow of ten prestigious academies and professional societies, including the Royal Society of Canada, the Canadian Academy of Engineering, and the American Institute for Medical and Biological Engineering, Dr. Radisic has received numerous distinctions such as the MIT Technology Review Top 35 Under 35, the Killam Fellowship, and the Humboldt Research Award.
Internationally recognized for pioneering organ-on-a-chip (OoC) engineering, her research focuses on developing biomaterials and microphysiological systems to model human organs and diseases. Her lab leverages induced pluripotent stem cells (iPSCs) to create functional human heart tissues and novel vascularization methods, advancing disease modeling and regenerative medicine.
Dr. Radisic serves as Executive Editor for ACS Biomaterials Science & Engineering and holds editorial positions with multiple leading journals. She is also the cofounder of two biotechnology companies: TARA Biosystems, acquired by Valo Health, and Quthero, which develops regenerative peptide-based materials. With over 260 publications, 26,000 citations, and an h-index of 81, her work appears in top journals including Cell, Nature Materials, and PNAS.
